InnoCare to Attend Upcoming Investor Conferences to Share Latest Company Development

BEIJING, Jan. 7, 2022 /PRNewswire/ — InnoCare Pharma (HKEX: 09969), a leading biotech company, announced today that the company executives will attend the upcoming investor conferences organized by Morgan Stanley and UBS to share company’s latest development. Details are as follows:…